Plasma Protein Fraction (Human)
Trade name: Plasmanate
Biologicalapproved
Approved
Oct 2, 1958
Clinical trial activity
1 trials · 1 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 9, 2019 (NCT05033704)
Timeline
Indications
Approved for
Mechanism of action
- PlasmaSupplementation
Plasma supplementation
Approval history
- approvedOct 2, 1958
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- NCATS6D53G0FD0Z ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05033704 | N/A | Sep 9, 2019 | Hamad Medical Corporation |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hamad Medical Corporation | For profit | 1 | 1 | 1 | 2019 |
1 organizations
Page 1 / 1